AI Science Tracker
EN

Early Screening of Colorectal Precancerous Lesions Based on Combined Measurement of Multiple Serum Tumor Markers Using Artificial Neural Network Analysis

Ruijin Hospital and College of Basic Medical Sciences; Xinhua Hospital; Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education; Institute of Artificial Intelligence Medicine · 27 Jun 2023 · medicine

Discovery

Early Screening of Colorectal Precancerous Lesions Based on Combined Measurement of Multiple Serum Tumor Markers Using Artificial Neural Network Analysis

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: ANN CA6 combines six measured serum tumor markers; Methods describes cohort and model construction. Results reports AUC 0.97 overall, 0.97 precancerous, 0.93 early CRC; retrospective cohort.

Technology: ANN CA6 combines six measured serum tumor markers; Methods describes cohort and model construction

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
ANN CA6 combines six measured serum tumor markers; Methods describes cohort and model construction
Limitation / still unknown
The findings are limited to the reported dataset, experimental setup and validation described in the source; broader generalization and real-world benefit were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/articles/PMC10377288 · https://pubmed.ncbi.nlm.nih.gov/37504084/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.